Skip to Content

Join the 'Relistor' group to help and get support from people like you.

Relistor News

Valeant and Progenics Announce FDA Approves Relistor Tablets for the Treatment of Opioid-Induced Constipation in Adults with Chronic Non-Cancer Pain

Posted 28 Jul 2016 by Drugs.com

LAVAL, Quebec and TARRYTOWN, N.Y., July 19, 2016 /PRNewswire/ – Valeant Pharmaceuticals International, Inc. (NYSE & TSX: VRX) and Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX) today announced that the U.S. Food and Drug Administration has approved Relistor (methylnaltrexone bromide) Tablets for the treatment of opioid-induced constipation (OIC) in adults with chronic non-cancer pain. Valeant ...

Ask a Question

Further Information

Related Condition Support Groups

Opioid-Induced Constipation, Constipation - Chronic, Constipation - Drug Induced

Relistor Patient Information at Drugs.com